clinical trial · NCT06970847
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
Prostate CancerProstate Cancer Patients With Detectable PSA Following ProstatectomyProstate Cancer RecurrentProstate Cancer Patients Who Have Brachytherapy Seed ImplantProstate Cancer Patients Treated by RadiotherapyCryotherapy64Cu-SAR-bisPSMA
brief summary
The aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer
started
May 16, 2025
primary completion
Dec 31, 2026
completion
Dec 31, 2026
last updated
Apr 9, 2026
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol